Suboptimal medication use and mortality in an older adult community-based cohort: Results from the hispanic EPESE study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 2, 2006, Pages 170-175

  Espino, David V ^a   Bazaldua, Oralia V ^a   Palmer, Raymond F ^a   Mouton, Charles P ^a,b   Parchman, Michael L ^a   Miles, Toni P ^a,c   Markides, Kyriakos ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c University of Louisville School of Medicine   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DRUG USE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL;

EID: 33644666123     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.2.170     Document Type: Article

References (31)

1. Priority Areas for National Action: Transforming Health Care Quality, 2003. Available at: http://www.nap.edu/openbook/0309085438/html/ 76.html. Accessed December 7, 2003.
2. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. N Engl J Med. 1991;324:377-384.
3. Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351:643-644.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205.
5. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.
6. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192-199.
7. Espino DV, Lichtnstein MJ, Hazuda HP, et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: The Hispanic EPESE Study. J Am Geriatr Soc. 1998;46:1228-1234.
8. Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 1992;8:143-158.
9. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.
10. Flaherty JH, Perry HM III, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol Med Sci. 2000;55A:M554-M559.
11. Golden AG, Preston RA, Barnett SD, et al. Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc. 1999;47:948-953.
12. Langdorf MI, Fox JC, Marwah RS. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000;7:1321-1329.
13. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA. 2001;286:2823-2829.
14. Black SA, Ray LA, Angel RJ, et al. Resource Book of the Hispanic Established Populations for Epidemiologic Studies of the Elderly. Ann Arbor, MI: National Archive for Computerized Data on Aging; 2003:1-5.
15. Bjerrum L, Sogaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen: a prescription database study. Eur J Clin Pharmacol. 1998;54:197-202.
16. Buckley BM. Healthy ageing: ageing safely. Eur Heart J. 2001; (3 Suppl):N6-N10.
17. Martin I, Hall J, Gardner T. Prescribing for patients aged 65 years and over in New Zealand general practice. N Z Med J. 2002;115:U221.
18. Kennerfalk A, Ruigomez A, Wallander MA, et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother. 2002;36:797-803.
19. Drug-Reax System. In: Gelman CR, Rumack BH, eds. Micromedex Intranet Knowledge Bases. Denver, CO: Micromedex, Inc; 2003.
20. Hazuda HP, Stern MP, Haffner SM. Acculturation and assimilation among Mexican Americans: scales and population-based data. Soc Sci Q. 1988;69:687-705.
21. Fillenbaum GG. Screening the elderly: a brief instrumental activities of daily living measure. J Am Geriatr Soc. 1985;33:698-706.
22. Anonymous. Mortality patterns-United States, 1997. MMWR Morb Mortal Wkly Rep. 1999;48:664-668.
23. SAS Institute Inc. SAS/STAT User's Guide. Version 6, 4th Ed., Vol. 1. Cary, NC: SAS Institute Inc; 1989.
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley and Sons; 1980.
25. Cox DR, Oakes D. Analysis of Survival Data. London, U.K.: Chapman and Hall; 1984.
26. Monane M, Monane S, Semla T. Optimal medication use in elders. Key to successful aging. West J Med. 1997;167:233-237.
27. Tanaka E. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther. 1999;24:87-92.
28. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001;58:1835-1841.
29. Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med. 1993;118:219-223.
30. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140:714-720.
31. Raji MA, Ostir GV, Markides KS, et al. Potentially inappropriate medication use by elderly Mexican Americans. Ann Pharmacother. 2003;37:1197-1202.